PTC Therapeutics said on Friday its inherited progressive muscle-wasting disorder drug will no longer be available for sale in the EU as the European Commission has decided not to renew its marketing ...

Arizona AG urges eligible consumers to claim compensation from a $39.1 million Apotex settlement over inflated generic drug ...

The pre-dawn raid, touted by Mayor Daniel Lurie and the San Francisco Police Department, was part of a new “drug market ...

The leadership of Onitsha Bridgehead Drug Market in Onitsha, Anambra State, popularly known as Ogbo-Ogwu, has dissociated ...

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

An entrenched and escalating drug market is creating chronic public safety issues in Seattle’s University District, according ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

PTC Therapeutics said on Friday its inherited progressive muscle-wasting disorder drug will no longer be available for sale in the EU as the European Commission has decided not to renew its ...